Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04581122

A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components

A multiple-center study on the effect of different ways of lymph node dissection on the prognosis of less than 3cm ground glass nodules with more than solid components

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Progression Disease Attributes Disease Progression Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jiang Wei

Shanghai, 200032, China

Location status: Recruiting

Location contact

Jiang Wei

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 18 and 75 years;
  • GGO is diagnosed by lung CT and failure to subside after 3 months (the patient having been re-examined by thin-section CT);
  • The maximum diameter of the GGO is smaller than 3cm;
  • The maximum diameter of the solid component in the GGO is more than 50%;
  • The patient is able to undergo the lobectomy
  • The patient is able to understand and comply with the study and has provided written informed consent.

Exclusion criteria

-

Patients meeting any of the following criteria are not eligible for this trial:

  • Patients with a history of using immunosuppressive or hormonal drugs;
  • Patients receiving radiotherapy or chemotherapy;
  • Patients who fail to comply with our follow-up strategy;
  • Other situations that are not in conformity with the standards and requirements of this trial.

Treatment and study plan

Lymphadenectomy

Procedure

Patients with ground glass nodules smaller than 3cm and with more than 50%solid components would randomly assigned to selective lymphadenectomy group or systematic lymph node dissection group

Primary outcomes

  1. overall survival (OS)

    Time frame: 5 years

    five year overall survival

Study contacts

Contact information is provided by the study sponsor or research team.

Jiang Wei, Dr

CONTACT

[email protected]

86-21-64041990 ext. 86-21-64041990

Sponsors and collaborators

Lead sponsor

Shanghai Zhongshan Hospital

Other

Registry information

Official study title

Zhongshan Hospital

Important dates

Study start
2020
Primary completion
2022
Study completion
2028
First posted
Oct 9, 2020
Registry last updated
Oct 9, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.